Novo Nordisk Aktie: Awiqli kostet 3,07 Dollar pro Woche
Novo Nordisk erobert den größten Diabetes-Markt der Welt mit einer radikalen Preisstrategie. Der dänische Pharmakonzern startet sein wöchentliches Basal-Insulin Awiqli in Indien – zu einem Bruchteil…
Read the full articlede
You might also wanna read
Sustainable development: EU Commission reports €60BN in imports under GSP scheme
ieu-monitoring.com·14m ago
Stocks stumble, oil set for weekly gain on renewed Gulf hostilities
globalbankingandfinance.com·21m ago
EU Commission clears €41M Greek state aid for farmers facing increased fertiliser prices
ieu-monitoring.com·26m ago
Dollar set for weekly drop as traders cut wagers on rate hikes
globalbankingandfinance.com·40m ago
Explosion near Al Udeid Air Base in Qatar amid regional tensions
Crypto Briefing·44m ago
Amazon’s chip business secures $225B in commitments as Trainium demand outpaces supply
Crypto Briefing·48m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.